The pan-BET inhibitor JQ1 robustly inhibited skeletal muscle differentiation marker transcript levels, suggesting a potential role of BET-BD1 in muscle cell differentiation, and raises questions about possible limitations in the therapeutic utility of pan-BETi in FSHD. Here, DNER is linked to Facioscapulohumeral dystrophy.